ARCHIVES

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

This article is from The Cancer Letter archive.

Vol. 31 No. 6 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

Freireich, Moertel Matched Up Again

February 20, 1981

How Elite Institutions Were Affected By A Decade of Constricted Funding

October 31, 2014

DCT Board Approves Management Support, Drug Storage Concepts

March 3, 1989

Includes 8-page Business & Regulatory Report.

April 11, 2003

In Brief: James Carr Replaces Murphy As Interim Director of Organ Systems Coordinating Center In N.Y.

August 16, 1985

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

March 8, 1985